Notably, both CDNF and MANF display neuroprotective effects that extend beyond Parkinson’s disease, embracing conditions like cerebral ischemia and spinocerebellar ataxia (Lindholm and Saarma 2010). This evidence concerns the gene MANF and Parkinson disease.